EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal - sources
October 02, 2014 at 09:43 AM EDT
BRUSSELS, Oct 2 (Reuters) - EU antitrust regulators will widen a probe into Zimmer Holdings Inc's $13.4 billion bid for Biomet Inc but clear Eli Lilly's offer for a Novartis AG unit, three people familiar with the matter said on Thursday.